News

Emergent BioSolutions and Mount Sinai Health System Announce Initiation of DOD-Funded Clinical Program to Evaluate COVID-19 Human Hyperimmune Globulin (COVID-HIG) Product Candidate for Prophylaxis

Tauriga Sciences Inc. Completes Payment for the Entirety of its 3rd Production Run of its Gelatin Free, CBD Infused Gum Drop Product, Branded as: Tauri-Gummies

12_29 PR Snapshot of Tauri-Gummies™ EU Trademark The Company has Received Confirmation from its Contract Manufacturer, Concerning the Arrival of...

Hepion Pharmaceuticals Data Safety Monitoring Board Recommends Continuation with Final Dose Cohort in Phase 2a ‘AMBITION’ Clinical Trial for Treatment of Advanced NASH

IMC Says There is Still Time for Federal Government to Put Canadian Patients First by Delaying January 1, 2021 Implementation of PMPRB’s Regulations and Guidelines

OTTAWA, ON / ACCESSWIRE / December 29, 2020 / Innovative Medicines Canada (IMC) issued the following statement today regarding the...

error: Content is protected !!